|
Ponte Nossa/VisiJet Merger Completed and Financing Received;
|
| Transaction Creates Publicly Traded Biomedical Company.
|
| IRVINE, Calif.--(BUSINESS WIRE)--Feb. 14, 2003--Ponte Nossa Acquisition Corp. PNSO and VisiJet Inc., a privately held ophthalmic device company, today announced
the completion of their merger.
|
|
|
| Under the terms of the merger, each share of VisiJet common stock will exchange for one share of Ponte Nossa common stock. The combined company will be renamed VisiJet. Effective immediately the company's stock will trade under the symbol OTCBB:VJET
and all PNSO stock becomes VJET stock. In addition, immediately prior to the merger, VisiJet closed an equity financing transaction with a group of private investors totaling $1,125,000.
|
|
|
| The newly formed VisiJet is the developer of a waterjet technology that uses a high-pressure micro beam of water to ablate
ocular tissue for a variety of ocular procedures. The company's first product, the patented, FDA-approved Hydrokeratome, uses the waterjet technology to cut the cornea as required in LASIK surgery.
|
|
|
| With post approval evaluations underway, the product will be promoted at the upcoming American Society of Cataract and
Refractive Surgeons annual meeting in San Francisco in April. In addition, VisiJet is developing the Pulsatome, a device that uses waterjet technology to remove cataracts -- the most performed surgical procedure in the world.
|
|
|
Contact Information:
Mitchell & Company PR for Ponte Nossa Acquisition Corp.
Diane Mitchell, 949/474-7020
E-mail: mitchellcompany@earthlink.net
|
|
|
W H I T E